Zobrazeno 1 - 10
of 219
pro vyhledávání: '"rotavirus disease"'
Autor:
A. S. Korovkin, G. M. Ignatyev
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 23, Iss 4, Pp 499-512 (2023)
Scientific relevance. Rotavirus disease and its consequences remain a leading vaccine-preventable cause of mortality in young children. Russia has not yet included rotavirus immunisation in the national vaccination schedule, but paediatric rotavirus
Externí odkaz:
https://doaj.org/article/2f4f64448fa34f2cb1cc746000ba0867
Publikováno v:
Symmetry, Vol 14, Iss 12, p 2641 (2022)
Many diseases are caused by viruses of different symmetrical shapes. Rotavirus particles are approximately 75 nm in diameter. They have icosahedral symmetry and particles that possess two concentric protein shells, or capsids. In this research, using
Externí odkaz:
https://doaj.org/article/da9fec4c36864dc885e7958a3887c59c
Autor:
K. M. Khametova, K. P. Alekseev, A. G. Yuzhakov, L. V. Kostina, S. A. Raev, M. I. Musienko, A. N. Mukhin, T. I. Aliper, G. K. Vorkunova, T. V. Grebennikova
Publikováno v:
Вопросы вирусологии, Vol 64, Iss 1, Pp 16-22 (2019)
Introduction. Rоtaviruses are amоng the leading causes of severe diarrhea in children all over the Wоrld. Vaccination is considered to be the mоst effective way to cоntrоl the disease. Currently available vaccines for prevention of rоtavirus i
Externí odkaz:
https://doaj.org/article/d7f633c82f7f480c94d3e5e1a9f45bdc
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 11, Pp 2760-2767 (2018)
Background: We performed a systematic review to evaluate factors affecting uptake of rotavirus vaccine amongst physicians, parents and health system. Methods: We identified 15 studies that met the inclusion criteria from 790 screened studies publishe
Externí odkaz:
https://doaj.org/article/cd2b7845bde048ec8608a8c5467b7fdb
Publikováno v:
The Journal of Infectious Diseases
Worldwide, rotavirus is the leading pathogen causing severe diarrhea in children and a major cause of under 5 years mortality. In 1998, the first rotavirus vaccine, RotaShield, was licensed in the United States but a rare adverse event, intussuscepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32009235e112db771495ea576140ae2
https://doi.org/10.1093/infdis/jiaa598
https://doi.org/10.1093/infdis/jiaa598
Autor:
Giovanni Gabutti, Rosa Prato, Elisabetta Franco, Antonella Mattei, Federico Marchetti, Francesco Vitale, Giovanni Vitali Rosati, Paolo Bonanni, Giorgio Conforti
Publikováno v:
Human Vaccines & Immunotherapeutics. 17:4636-4645
Rotavirus (RV) causes up to half of hospital and community acute gastroenteritis (AGE) cases in young children in Italy. Two RV vaccines, available since 2006, are human RV (HRV) and human bovine RV (HBRV). This report looks back at the implementatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4d158b869057e3a363927acf7735a1
https://doi.org/10.1080/21645515.2021.1955611
https://doi.org/10.1080/21645515.2021.1955611
Autor:
Erkin Musabaev, Laziz Tuychiev, Manzura Akramova, Umid Eraliev, Renat Latipov, Kamola Safaeva, Annemarie Wasley, Boris Pleshkov, Vazira Mutalova, Mehri Sultanova, Dilbar Yuldashova, Michael D. Bowen, Dovile Videbaek, Dilorom Tursunova, Bahodir Barakaev, Said Sharapov, Danni S. Daniels, Umesh D. Parashar, Shahin Huseynov, Margaret M. Cortese, Umed Ismoilov, Slavica Mijatovic-Rustempasic
Publikováno v:
Hum Vaccin Immunother
Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5b8cf83673e777c1f161f623665c03
https://doi.org/10.1080/21645515.2020.1776034
https://doi.org/10.1080/21645515.2020.1776034
Autor:
Sidhartha Giri, Varanasi Gopalkrishna, Biswajyoti Borkakoty, C. P. Girish Kumar, Subarna Roy, Shobha D. Chitambar, Pradeep Das, Rashmi Arora, Pratima Ray, Vijayachari Paluru, Mamta Chawla-Sarkar, Gagandeep Kang, S. Venkatasubramanian, Jyothi Bhat, Bhagirathi Dwibedi, Sanjay Mehendale
Publikováno v:
Vaccine
BACKGROUND Rotavirus is an important cause of severe diarrhea requiring hospitalization, accounting for approximately 78,000 deaths annually in Indian children below 5 years of age. We present epidemiological data on severe rotavirus disease collecte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290c7b3c9b9bd161a0c4b7ee367af1e0
http://europepmc.org/articles/PMC7694878
http://europepmc.org/articles/PMC7694878
Publikováno v:
Expert review of pharmacoeconomics & outcomes research, 20(6), 603-612. Taylor & Francis Group
Background: The economics of rotavirus gastroenteritis in infants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f275d8fbd5c6248a9cba5e1544bf621
https://research.rug.nl/en/publications/ed868b27-8758-4503-bd8d-917baca7f5ef
https://research.rug.nl/en/publications/ed868b27-8758-4503-bd8d-917baca7f5ef
Publikováno v:
Discrete & Continuous Dynamical Systems - B. 25:3373-3391
A two-strain rotavirus model with vaccination and homotypic protection is proposed to study the survival of the two strains of rotavirus within the host. Corresponding to the different efficacy of monovalent vaccine against different strains, the vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8d753ef9ad64d53f7bed9f259236c93
https://doi.org/10.3934/dcdsb.2020066
https://doi.org/10.3934/dcdsb.2020066